Oncoarendi Therapeutics SA operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncoarendi Therapeutics SA with three other
pharmaceutical manufacturers in Europe:
Biomed Lublin Wytwornia Surowic I Szczepionek SA
sales of 40.16 million Polish New Zlotys [US$10.56 million]
of which 100%
was Traditional Segment),
(25.84 million Euros [US$30.94 million]
of which 40%
was Lipids), and
based in FRANCE
(9.34 million Euros [US$11.19 million]
of which 68%
was Research & Development Tax Credit).